FDA issues warning on use of kratom
WASHINGTON – The Food and Drug Administration on Tuesday issued a strong warning to consumers to stay away from the herbal supplement kratom, saying regulators are aware of 36 deaths linked to products containing the substance.
Consumers are increasingly using the supplement, which comes from a plant in Southeast Asia, for pain, anxiety and depression, as well as symptoms of opioid withdrawal.
Because it produces symptoms, such as euphoria, similar to opiates, it is also used recreationally. Proponents say it is a safe way to deal with chronic pain and other ailments, and some researchers are exploring its therapeutic potential, including helping people overcome addictions.
FDA commissioner Scott Gottlieb said there is no “reliable evidence” to support the use of kratom as a treatment for opioid-use disorder, and that there are no other FDAapproved uses of kratom.
– New York Times